SCIENTIFIC PROGRAMME

Click on each day to view the programme. Please note that sessions; speakers and chairs are continously being updated.

This page was last updated: 31 May 2010

SATURDAY

SUNDAY

MONDAY

TUESDAY

WEDNESDAY

TUESDAY 8 JUNE

MEET THE EXPERT
Pre-registration required.

07.30 - 08.15

MTE 17 - Filaggrin and allergy

Alan Irvine, Ireland
Jonathan Hourihane, Ireland

MTE 18 - Mastocytosis and hypereosinophilia

Clive Grattan, United Kingdom
Florence Roufousse, Belgium

MTE 19 - Component-resolved diagnosis

Adriano Mari, Italy
Thomas Werfel, Germany

MTE 20 - Immunotherapy: mechanisms

Barbara Bohle, Austria
Stephen Durham, United Kingdom

MTE 21 - Occupational allergy

Paul Cullinan, United Kingdom
Gianna Moscato, Italy

MTE 22 - Genetics of asthma

Francine Kauffmann, France

MTE 23 - Difficult issues in the dietary management of food allergy

Rosan Meyer, United Kingdom

MTE 24 - Managing severe persistent adult asthma

Andrew Wardlaw, United Kingdom
Ian Pavord, United Kingdom

MTE 25 - Animal models of asthma

Clare Lloyd, United Kingdom
Paul Foster, Australia

08.30 – 10.00

Plenary Symposium 5 - IgE and anaphylaxis

Chairs:
Cezmi Akdis, Switzerland
Hannah Gould, United Kingdom

Structure of IgE
Brian Sutton, United Kingdom

Regulation of specific and total IgE
Donata Vercelli, United States

Mechanisms of anaphylaxis
Peter Vadas, Canada

Management of anaphylaxis
Ulrich Müller, Switzerland

Plenary Symposium 6 - The phenotypes of asthma and rhinitis

Chairs:
Ömer Kalayci, Turkey
Andrew Wardlaw, United Kingdom

Phenotypes of asthma in children
Claudia Kuehni, Switzerland

The role of allergy in asthma
Christian Virchow, Germany

Phenotype guided management of asthma
Ian Pavord, United Kingdom

Implications for our understanding of rhinitis
Glenis Scadding, United Kingdom

10.00 – 10.30 Coffee break

10.30 – 12.00

Symposium 24 - Insect venom hypersensitivity

Chairs:
Beatrice Bilò, Italy
Ulrich Müller, Switzerland

Potential effects of global warming on hymenoptera biology and the risk of stings
Volker Mauss, Germany

Clinical impact of risk factors in hymenoptera venom allergy
Franziska Ruëff, Germany

Improving diagnosis of hymenoptera venom allergy
Gunter Sturm, Austria

Symposium 25 - Molecular mimicry leading to allergy and autoimmunity: a new challenge

Chairs:
Marek Jutel, Poland
Francois Spertini, Switzerland

Pemphigus - non-infectious and infectious trigger factors
Michael Hertl, Germany

Atopic dermatitis and microbial agents
Peter Schmid-Grendelmeier, Switzerland

Molecular mimicry to aeroallergens
Marsha Wills-Karp, United States

Symposium 26 - The clinical relevance of small airways in asthma: an emerging therapeutic target

Chairs:
Richard Lockey, United States
Christian Virchow, Germany

Clinical importance of small airways in asthma
Leif Bjermer, Sweden

Pathopysiology of small airways disease in asthma
Lanny Rosenwasser, United States

Therapeutic implications: innovations in aerosol delivery
Monica Kraft, United States

Symposium 27 - Cutaneous contact allergies: old challenges newly reviewed

Chairs: Antti Lauerma, Finland
Klaus Ejner Andersen, Denmark

Airborne contact dermatitis
An Goossens, Belgium

Compositae dermatitis
Klaus Ejner Andersen, Denmark

Contact urticaria
Kriistina Aalto-Korte, Finland

Multiple contact allergies
Margitta Worm, Germany

Company Sponsored Symposium - MSD Intranasal steroids for the treatment of inflammatory upper airway diseases: how strong is the clinical evidence?

Chair:
Wytske Fokkens, The Netherlands

Welcome and Introduction
Wytske Fokkens, The Netherlands

Managing the nasal and ocular symptoms of allergic rhinitis: examining the evidence for intranasal steroids
Nasal symptoms: Valerie Lund, United Kingdom
Ocular symptoms: Leonard Bielory, United States

Treatment of acute rhinosinusitis with and without nasal polyposis: what is the role of intranasal steroids?
Wytske Fokkens, The Netherlands

Pharmacological differences between intranasal steroids: are they clinically relevant?
Guenther Hochhaus, United States

Question and answers/Panel discussion
Wytske Fokkens, The Netherlands

Company Sponsored Symposium - Airsonett Successful control of particulate exposure modifies allergic airway diseases – a truly novel approach using Temperature controlled Laminar Airflow (TLA)

Chairs:
Ronald Dahl, Denmark
Olle Zetterström, Sweden

Air quality and airway disease
Frank Kelly, United Kingdom

Temperature controlled laminar airflow: principles and practice
Torben Sigsgaard, Denmark

Non-pharmacological management of rhinitis and asthma
John Warner, United Kingdom

Results of the 4A trial
Magnus Wickman, Sweden
Ronald Dahl, Denmark

Workshop 8 - Rapid desensitisation in drug allergy

Chairs:
Shuaib Nasser, United Kingdom
Pascal Demoly, France

Chemotherapy
Mariana Castells, United States

Biologicals
Hans Jürgen Hoffmann, Denmark

NSAIDs
Marek Kowalski, Poland

Workshop 9 - GI manifestations of food allergy in childhood

Chairs: 
Philippe Eigenmann, Switzerland 
Els van Hoffen, The Netherlands

Gastro-oesophageal reflux and eosinophilic oesophagitis
Alberto Ravelli, Italy

Food enteropathies and colitis
Katie Allen, Australia

Dietary management of food allergy
Kate Grimshaw, United Kingdom

Clinical Update 5 - Modern treatment of allergic airway disease

Chairs:
Victoria Cardona, Spain
Livije Kalogjiera, Croatia

Optimal treatment of allergic rhinitis
Peter Howarth, United Kingdom

Optimising therapy for asthma
Maarten van den Berge, The Netherlands

Immunotherapy for asthma and rhinitis
Walter Canonica, Italy

COST Workshop - Therapeutic potential of histamine H4 receptor compounds

Chairs:
Madeleine Ennis, United Kingdom 
Katherine Tiligada, Greece 

The H4R in allergic airway disease
Steven Liu, United Kingdom

Role of H4R in inflammatory skin disease
Thomas Werfel, Germany

H4R antagonists as future anti-inflammatory drugs
Robin Thurmond, United States

Hot Topic 4 - New approaches to immunomodulation of allergic disease

Chairs:
Enrico Compalati, Italy
Markus Ollert, Germany

Bacteriophage coupled Fel-d1: a novel immunotherapy agent for cat allergy 
Martin Bachmann, Switzerland 

Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivities
Jan Ceuppens, Belgium

Dendritic cells as a therapeutic target for the treatment of atopic dermatitis
Thomas Bieber, Germany

OAS 21 - New tools in occupational allergy

Chairs:
Santiago Quirce, Spain
Gianna Moscato, Italy

Introductory lecture by Santiago Quirce: Implementation of new tools in the diagnosis of occupational allergy

OAS 22 - Risk factors for asthma

Chairs:
Erika von Mutius, Germany
Gert-Jan Braunstahl, The Netherlands

PDS 17- Immunogenetics and immunogenomics

Chairs:
Lars Poulsen, Denmark
Reto Crameri, Switzerland

PDS 18 - Highlights in molecular allergology

Chairs:
Adriano Mari, Italy
Jörg Kleine-Tebbe, Germany

PDS 19 - Allergen exposure and sensitisation

Chairs:
Jeroen Buters, Germany
Carmen Galán, Spain

PDS 20 - Immunotherapy: special clinical problems

Chairs:
Moises Calderon, United Kingdom
Carlo Lombardi, Italy

12.00 – 13:30 LUNCH & POSTER VIEWING

12.30 – 13:00 The Ring of Pro & Con 4 - Rhinitis causes asthma

Chair:
Claus Bachert, Belgium

Pro: Walter Canonica, Italy
Con: Jean Bousquet, France

13.00 – 13.30 The Ring of Pro & Con 5 - Pollution is important in asthma

Chair:
Lorenzo Cecchi, Italy

Pro: Gennaro D’Amato, Italy
Con: Carlos Nunes, Portugal

Practical Hands-on Session 2

Workstation facilitators:
Fiona Chew, United Kingdom
Justine Allen, United Kingdom
Celia Proudfoot, United Kingdom
Jennifer Whisken, United Kingdom
Rebecca Elder, United Kingdom
Lisa Slater, United Kingdom
Andrew Williams, United Kingdom

13.30 – 15.00

Symposium 28 - Triggers for asthma exacerbations

Chairs:
Susanne Lau, Germany
Chris Brightling, United Kingdom

Exercise
Kai-Håkon Carlsen, Norway

Food
Graham Roberts, United Kingdom

Alcohol
Allan Linneberg, Denmark

Symposium 29 - Hypereosinophilic syndrome

Chairs:
Hans-Uwe Simon, Switzerland
Junichi Chihara, Japan

Classification and diagnosis of hypereosinophilic syndrome
Florence Roufosse, Belgium

Myeloproliferative forms of hypereosinophilia
Andreas Reiter, Germany

Management of hypereosinophilic syndrome
Andrew Wardlaw, United Kingdom

Symposium 30 - Component-resolved diagnosis and treatment

Chairs:
Jörg Kleine-Tebbe, Germany
Claudio Rhyner, Switzerland 

Component-resolved allergens
Verena Niederberger, Austria

Component-resolved diagnosis
Adriano Mari, Italy

Treatment
Marek Jutel, Poland

Symposium 31 - Innate immune responses

Chairs:
Jürgen Schwarze, United Kingdom 
Harald Renz, Germany

Innate immunity and contact dermatitis
Stefan Martin, Germany

C-type lectins
Liam O’Mahony, Switzerland

Nod receptors
Lars Olaf Cardell, Sweden

Symposium 32 - Histamine: the first hundred years

Chairs:
Cezmi Akdis, Switzerland
Claus Bachert, Belgium

From Dale to now: understanding histamine and its receptors
Martin Church, United Kingdom

The development of H1-antihistamines
Estelle Simons, Canada

The use (and limitations) of antihistamines in allergic disease
Livije Kalogjera, Croatia

Company Sponsored Symposium – ALK Disease-modifying effect of specific immunotherapy – control, sustain, prevent

Chair
Adnan Custovic, United Kingdom

Effective disease control with SIT - can we offer our patients more?
Natalija Novak, Germany

Sustained disease control with SIT - do we really treat the cause?
Stephen Durham, United Kingdom

Preventive effect of SIT - can we stop our patients walking the Allergic March?
Eric Bateman, South Africa

Changing the management of allergy - the future is in our hands
Henrik Jacobi, Denmark

Workshop 10 - Bring your own patient – adults

Convenor
Rubaiyat Haque, United Kingdom

Panellist
Shuaib Nasser, United Kingdom

Panellist
Meir Shalit, Israel

Panellist
Joe Unsworth, United Kingdom

Panellist
Wiqar Shaikh, India

Workshop 11 - Neuro-allergy

Chairs:
Guy Joos, Belgium
Wytske Fokkens, The Netherlands

Neurotransmitters in urticaria
George Konstantinou, Greece

Neuropeptides in atopic dermatitis
Ulrike Raap, Germany

Neuropeptides in rhinitis
James Baraniuk, United States

Clinical Update 6 - Atopic dermatitis for the non-dermatologist

Chairs:
Torsten Zuberbier, Germany
Magdalena Czarnecka-Operacz, Poland

Differential diagnosis and the role of allergy in atopic dermatitis
Suzanne Pasmans, The Netherlands

Management
Helen Cox, United Kingdom

Novel approaches
Dagmar Simon, Switzerland

13.30 – 14.15 Debate 5 - Specific IgE can replace food challenges in diagnosing food allergy

Chair:
Andrew Clark, United Kingdom

Pro: Philippe Eigenmann, Switzerland
Con: Gideon Lack, United Kingdom

14.15 – 15.00 Debate 6 - New birth cohorts in allergy should be funded

Chair:
Angela Simpson, United Kingdom

Pro: Jonathan Hourihane, Ireland
Con: Kirsten Beyer, Germany

OAS 23 - Viruses and parasites as determinants for allergic inflammation

Chairs:
Maria Yazdanbakhsh, The Netherlands
Chrysanthi Skevaki, Greece

Introductory lecture by Maria Yazdanbakhsh: When and how do parasites protect from allergy?

OAS 24 - Drug hypersensitivity: from mechanisms to treatment

Chairs:
Maria José Torres, Spain
Hee-Bom Moon, Korea

Introductory lecture by Maria Jose Torres: Non-immidiate drug reactions

OAS 25 - T cell biology in allergy and asthma

Chairs:
Carsten Schmidt-Weber, Germany
Barbara Bohle, Austria

Introdutory lecture by Carsten Schmidt-Weber: T lymphocytes in allergy

OAS 26 - Immunology of asthma

Chairs:
Andreas Jung, Switzerland
Joao Fonseca, Portugal

Introductory lecture by Andreas Jung: Immunology of asthma

OAS 27 - Allergic conjunctivitis

Chairs:
Sergio Bonini, Italy
Peter Hellings, Belgium

Introductory lecture by Sergio Bonini: Update on allergic rhino-conjunctivitis

Business Meeting Insect Venom Hypersensitivity Interest Group

Chairs:
Beatrice Bilò, Italy
Franziska Ruëff, Germany

15.00 – 15.30 Coffee break

15.30 – 17.00

Symposium 33 - Aerobiology

Chairs:
Anand Singh, India
Gennaro D'Amato, Italy

Pollen aerobiology: measurement and consequences of exposure
Carmen Galan, Spain

Fungal aerobiology: measurement and consequences of exposure
Elliott Horner, United States

The HIALINE project: allergen release from pollen across 10 European countries
Jeroen Buters, Germany

Symposium 34 - Auto-inflammatory syndromes

Chairs:
Richard Powell, United Kingdom
Oscar Palomares, Switzerland

Overview of auto-inflammatory syndromes
Anna Simon, The Netherlands

The inflammasome in auto-inflammatory syndromes
Seth Masters, Ireland

Managing amyloidosis
Philip Hawkins, United Kingdom

Company Sponsored Symposium - Uriach Evolving strategies to control both allergic inflammation and symptoms

Chairs:
Glenis Scadding, United Kingdom
Jean Bousquet, France

Chairs' welcome and introduction
Glenis Scadding, United Kingdom
Jean Bousquet, France

Down-regulation of histamine and PAF in allergic inflammation
Estelle Simons, Canada

Urticaria management – treatment choices and interpretation
Clive Grattan, United Kingdom

New studies on the use of non sedating antihistamines in the management of allergic rhinitis in children
Paul Potter, South Africa

Discussion and concluding remarks
Moderated by
Glenis Scadding, United Kingdom
Jean Bousquet, France

Workshop 12 - New molecules in asthma and rhinitis

Chairs:
Peter Howarth, United Kingdom
Ioana Agache, Romania

Osteopontin
Frank Redegeld, The Netherlands

Protease inhibitors
Ömer Kalayci, Turkey

Regulation of airway inflammation by micro - RNA
Paul Foster, Australia

Workshop 13 - Bring your own patient – children

Covenor
Adam Fox, United Kingdom

Panellist
Désirée Larenas-Linnemann, Mexico

Panellist
Antonella Muraro, Italy

Panellist
Andrew Clark, United Kingdom

Panellist
William Berger, United States

Hot Topic 5 - New insights into the mechanisms of allergic disease

Chairs:
Robyn O'Hehir, Australia
Qutayba Hamid, Canada

Immune regulation in allergy: looking beyond regulatory T cells
Thilo Jakob, Germany

Anti-acid medication as a risk factor for food allergy
Erika Jensen-Jarolim, Austria

Measurement of novel mediators in exhaled air in asthma
Marek Sanak, Poland

Year in Review 3 – Clinical II

Chairs:
Meir Shalit, Israel
Carsten Bindslev-Jensen, Denmark

Atopic eczema
Donald Leung, United States

Food allergy
Denise-Anne Moneret-Vautrin, France

Drug allergy
Sevim Bavbek, Turkey

Aerobiology
Carlos Nunes, Portugal

PDS 21 - News in drug allergy

Chairs:
Maria José Torres, Spain
Werner Aberer, Austria

Clinical Update 7 - Ocular allergy

Chairs:
Sergio Bonini, Italy
Virginia Calder, United Kingdom

Identifying allergic and non-allergic eye disease
Connie Katelaris, Australia

Inflammatory eye disease: when to treat and when to refer
Melanie Hingorani, United Kingdom

Novel treatment options for ocular allergy
Stefano Bonini, Italy

Business Meeting Asthma Section

Chair:
Adnan Custovic, United Kingdom

Cough in asthma
Ashley Woodcock, United Kingdom

Business Meeting Dermatology Section

Chair:
Peter Schmid-Grendelmeier, Switzerland

Life-threatening cutaneous drug reactions
Antonio Cozzio, Italy

Business Meeting ENT Section

Chair:
Livije Kalogjera, Croatia

Mouse models can explain allergic airway disease in humans

Pro: Peter Hellings, Belgium
Con: Ruby Pawankar, Japan

Business Meeting Immunology Section

Chair:
Barbara Bohle, Austria

IL-10:an important regulator of innate and adaptive immune responses
Anne O´Garra, United Kingdom

Business Meeting Pediatric Section

Chair:
Susanne Halken, Denmark

Clinical approach to the patient with suspected immunodeficiency
Bobby Gaspar, United Kingdom

PDS 22 - Identification and modification of novel food and other allergens

Chairs:
Karin Hoffmann-Sommergruber, Germany
Montserrat Fernandez-Rivas, Spain

PDS 23 - Asthma: epidemiology and risk factors

Chairs:
Allan Linneberg, Sweden
Feyzullah Cetinkaya, Turkey

PDS 24 - Risk factors and genetics

Chairs:
Christian Scharf, Germany
Angela Simpson, United Kingdom

17.30 – 19.00

JMA Business Meeting & Awards

Chair:
Chrysanthi Skevaki, Greece

19.00 - 23.00 JMA Evening Event

TUESDAY 8 JUNE 12.00 - 13.30 - POSTER GROUP III

Asthma II

Asthma: exercise and management
Chairs:
Ioana Agache, Romania
Jan de Monchy, The Netherlands

Asthma management I
Chairs:
Svetlana Sergejeva, Estonia
Douglas Robinson, United Kingdom

Asthma management II
Chairs:
Joao Fonseca, Portugal
Sevim Bavbek, Turkey

Toward understanding asthma pathogenesis
Chairs:
Hae Sim Park, Korea
Alain Didier, France

Asthma mechanisms and management
Chairs:
Stefano Del Giacco, Italy
Maria Dolores Hernandez, Spain

Asthma mechanisms
Chairs:
Piero Maestrelli, Italy
Ted Popov, Bulgaria

Clinical Allergy

Immunotherapy: clinical aspects
Chairs:
Eva-Maria Varga, Austria
Ralph Mösges, Germany

Immunotherapy: novel clinical aspects
Chairs:
Albrecht Bufe, Germany
Carmen Moreno-Aguilar, Spain

Patient-related outcomes: quality of life, compliance and costs
Chairs:
Gianenrico Senna, Italy
Emilio Alvares Cuesta, Spain

Adult anaphylaxis: diagnosis and management
Chairs:
Rene Crevel, United Kingdom
André Knulst, The Netherlands

Dermatology III

The challenge of allergic skin diseases
Chairs:
George Konstantinou, Greece
Elena Borzova, Russia

Skin allergy in all its facets
Chairs:
Radoslaw Spiewak, Poland
Carsten Bindslev-Jensen, Denmark

Drug Allergy II

NSAID intolerance
Chairs:
Marek Sanak, Poland
Gul Karakaya, Turkey

Drug allergy: miscellaneous
Chairs:
Ingrid Terreehorst, The Netherlands
Hans Merk, Germany

Drug allergy: endocrinology and diagnostic work ups
Chairs:
Stefan Wöhrl, Austria
Knut Brockow, Germany

ENT II

Rhinitis, diagnosis and clinical features
Chairs:
Pongsakorn Tantilipikorn, Thailand
Joaquín Sastre, Spain

Sinusitis and polyps
Chairs:
Guiseppina Rotiroti, Italy
Cesar Picado, Spain

Infections & Allergy

Immunological aspects of infections
Chairs:
Sebastian Johnston, United Kingdom
Philippe Gevaert, Belgium

Innate and adaptive immunity II
Chairs:
Tunc Akkoc, Turkey
Hans Jürgen Hoffmann, Denmark

Insect Venom Hypersensitivity

Insect venom hypersensitivity
Chairs:
Marek Niedoszytko, Poland
Gunter Sturm, Austria

Occupational

Occupational allergy
Chairs:
Elina Toskala, Finland
Gert Doekes, The Netherlands

Pediatric Asthma

Pediatric respiratory disease: epidemiology
Chairs:
Nikos Papadopoulos, Greece
Carlos Baena-Cagnani, Argentina

Pediatric asthma: epidemiology
Chairs:
Thomas Keil, Germany
Paolo Matricardi, Italy

Pediatric asthma: risk factors and pathogenesis
Chairs:
Karin Lødrup Carlsen, Norway
Maria Xatzipsalti, Greece

Pediatric asthma: diagnosis, treatment and monitoring
Chairs:
Andreas Jung, Switzerland
Jürgen Seidenberg, Germany

Late Breaking Posters

Infection and immunity
Chairs:
Hasan Yuksel, Turkey
Erika Jensen-Jarolim, Austria

Miscellaneous
Chairs:
Ozlem Keskin, Turkey
Chrysanthi Skevaki, Greece

Food allergy
Chairs:
Aysen Bingol Boz, Turkey
Vera Mahler, Germany

Epidemiology of allergic diseases
Chairs:
Francine Kauffmann, France
Roger Lauener, Switzerland

Back to the top